The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing (20 - 21) Manufacture of chemicals and pharmaceuticals 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations 21.20 - Manufacture of pharmaceutical preparations
100 jobs Number of planned job creations
Announcement Date
11 March 2022
Employment effect (start)
11 March 2022
Foreseen end date
31 December 2022
Description
The Swedish group Recipharm has announced the recruitment of 100 people at its plant in Monts (Indre-et-Loire). New positions will be on permanent and fixed-term contracts (generally for more than 6 months). The site produces Moderna's COVID-19 vaccine in bottles and will install a fifth production line. In 2021, the state invested €35 million in the plant, as part of the recovery plan program. Two recruitment days are planned at the plant: on April 7 and May 7. The 5th line should be operational in July.
Headquartered in Stockholm, Recipharm is a leading contract development and manufacturing organisation (CDMO) in the pharmaceutical sector. It currently employs nearly 300 people in France.
Eurofound (2022), Recipharm, Business expansion in France, factsheet number 106572, European Restructuring Monitor. Dublin, https://apps.eurofound.europa.eu/restructuring-events/detail/106572.